Prospective Registry to Asses the Long-term Safety and Performance of the Combo Stent (REMEDEE Reg)
|ClinicalTrials.gov Identifier: NCT01874002|
Recruitment Status : Active, not recruiting
First Posted : June 10, 2013
Last Update Posted : December 30, 2015
Robbert J de Winter
Information provided by (Responsible Party):
Robbert J de Winter, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Active, not recruiting|
|Primary Completion Date :||March 2015|
|Estimated Study Completion Date :||March 2019|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Kalkman DN, Woudstra P, Menown IBA, den Heijer P, Van't Hof AW, Erglis A, Suryapranata H, Arkenbout KE, Iñiguez A, Muller P, Tijssen JG, Beijk MAM, de Winter RJ. Two-year clinical outcomes of patients treated with the dual-therapy stent in a 1000 patient all-comers registry. Open Heart. 2017 Jul 11;4(2):e000634. doi: 10.1136/openhrt-2017-000634. eCollection 2017.
Woudstra P, Kalkman DN, den Heijer P, Menown IB, Erglis A, Suryapranata H, Arkenbout KE, Iñiguez A, van 't Hof AW, Muller P, Tijssen JG, de Winter RJ. 1-Year Results of the REMEDEE Registry: Clinical Outcomes After Deployment of the Abluminal Sirolimus-Coated Bioengineered (Combo) Stent in a Multicenter, Prospective All-Comers Registry. JACC Cardiovasc Interv. 2016 Jun 13;9(11):1127-34. doi: 10.1016/j.jcin.2016.02.052. Epub 2016 May 18.